Literature DB >> 22653753

Postnatal inactivation reveals enhanced requirement for MeCP2 at distinct age windows.

Hélène Cheval1, Jacky Guy, Cara Merusi, Dina De Sousa, Jim Selfridge, Adrian Bird.   

Abstract

Rett Syndrome is a neurological disorder caused by mutations in the X-linked MECP2 gene. Mouse models where Mecp2 is inactivated or mutated recapitulate several features of the disorder and have demonstrated a requirement for the protein to ensure brain function in adult mice. We deleted the Mecp2 gene in ~80% of brain cells at three postnatal ages to determine whether the need for MeCP2 varies with age. Inactivation at all three time points induced Rett-like phenotypes and caused premature death of the animals. We find two threshold ages beyond which the requirement for MeCP2 markedly increases in stringency. The earlier threshold (8-14 weeks), when inactivated mice develop symptoms, represents early adulthood in the mouse and coincides with the period when Mecp2-null mice exhibit terminal symptoms. Unexpectedly, we identified a later age threshold (30-45 weeks) beyond which an 80% reduction in MeCP2 is incompatible with life. This finding suggests an enhanced role for MeCP2 in the aging brain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22653753      PMCID: PMC3412380          DOI: 10.1093/hmg/dds208

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  28 in total

1.  Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA.

Authors:  J D Lewis; R R Meehan; W J Henzel; I Maurer-Fogy; P Jeppesen; F Klein; A Bird
Journal:  Cell       Date:  1992-06-12       Impact factor: 41.582

2.  A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.

Authors:  J Guy; B Hendrich; M Holmes; J E Martin; A Bird
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

3.  Survival with Rett syndrome: comparing Rett's original sample with data from the Australian Rett Syndrome Database.

Authors:  Michael Freilinger; Ami Bebbington; Ines Lanator; Nick De Klerk; Daniela Dunkler; Rainer Seidl; Helen Leonard; Gabriel M Ronen
Journal:  Dev Med Child Neurol       Date:  2010-06-22       Impact factor: 5.449

4.  Two affected boys in a Rett syndrome family: clinical and molecular findings.

Authors:  L Villard; A Kpebe; C Cardoso; P J Chelly; P M Tardieu; M Fontes
Journal:  Neurology       Date:  2000-10-24       Impact factor: 9.910

5.  Longevity in Rett syndrome: analysis of the North American Database.

Authors:  Russell S Kirby; Jane B Lane; Jerry Childers; Steve A Skinner; Fran Annese; Judy O Barrish; Daniel G Glaze; Patrick Macleod; Alan K Percy
Journal:  J Pediatr       Date:  2010-01       Impact factor: 4.406

6.  An altered neonatal behavioral phenotype in Mecp2 mutant mice.

Authors:  Jonathan D Picker; Rebecca Yang; Laura Ricceri; Joanne Berger-Sweeney
Journal:  Neuroreport       Date:  2006-04-03       Impact factor: 1.837

7.  Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain.

Authors:  B C Mullaney; M V Johnston; M E Blue
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

8.  Defective body-weight regulation, motor control and abnormal social interactions in Mecp2 hypomorphic mice.

Authors:  Bredford Kerr; Matías Alvarez-Saavedra; Mauricio A Sáez; Alexandra Saona; Juan I Young
Journal:  Hum Mol Genet       Date:  2008-03-04       Impact factor: 6.150

9.  Adult neural function requires MeCP2.

Authors:  Christopher M McGraw; Rodney C Samaco; Huda Y Zoghbi
Journal:  Science       Date:  2011-06-02       Impact factor: 47.728

10.  A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome.

Authors:  Rodney C Samaco; John D Fryer; Jun Ren; Sharyl Fyffe; Hsiao-Tuan Chao; Yaling Sun; John J Greer; Huda Y Zoghbi; Jeffrey L Neul
Journal:  Hum Mol Genet       Date:  2008-03-04       Impact factor: 6.150

View more
  46 in total

Review 1.  Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders.

Authors:  Sacha B Nelson; Vera Valakh
Journal:  Neuron       Date:  2015-08-19       Impact factor: 17.173

2.  Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome.

Authors:  Jorge Castro; Rodrigo I Garcia; Showming Kwok; Abhishek Banerjee; Jeremy Petravicz; Jonathan Woodson; Nikolaos Mellios; Daniela Tropea; Mriganka Sur
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

3.  Acute and crucial requirement for MeCP2 function upon transition from early to late adult stages of brain maturation.

Authors:  Fang Du; Minh Vu Chuong Nguyen; Ariel Karten; Christy A Felice; Gail Mandel; Nurit Ballas
Journal:  Hum Mol Genet       Date:  2016-02-16       Impact factor: 6.150

4.  Human-specific regulation of MeCP2 levels in fetal brains by microRNA miR-483-5p.

Authors:  Kihoon Han; Vincenzo Alessandro Gennarino; Yoontae Lee; Kaifang Pang; Kazue Hashimoto-Torii; Sanaa Choufani; Chandrasekhar S Raju; Michael C Oldham; Rosanna Weksberg; Pasko Rakic; Zhandong Liu; Huda Y Zoghbi
Journal:  Genes Dev       Date:  2013-02-21       Impact factor: 11.361

Review 5.  Rett syndrome: disruption of epigenetic control of postnatal neurological functions.

Authors:  Amy E Pohodich; Huda Y Zoghbi
Journal:  Hum Mol Genet       Date:  2015-06-09       Impact factor: 6.150

6.  The neural circuit basis of Rett syndrome.

Authors:  Darren Goffin; Zhaolan Joe Zhou
Journal:  Front Biol (Beijing)       Date:  2012-10

7.  Oligodendrocyte lineage cells contribute unique features to Rett syndrome neuropathology.

Authors:  Minh Vu Chuong Nguyen; Christy A Felice; Fang Du; Matthew V Covey; John K Robinson; Gail Mandel; Nurit Ballas
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

8.  Loss of MeCP2 from forebrain excitatory neurons leads to cortical hyperexcitation and seizures.

Authors:  Wen Zhang; Matthew Peterson; Barbara Beyer; Wayne N Frankel; Zhong-wei Zhang
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

9.  NMDA receptor regulation prevents regression of visual cortical function in the absence of Mecp2.

Authors:  Severine Durand; Annarita Patrizi; Kathleen B Quast; Lea Hachigian; Roman Pavlyuk; Alka Saxena; Piero Carninci; Takao K Hensch; Michela Fagiolini
Journal:  Neuron       Date:  2012-12-20       Impact factor: 17.173

10.  Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).

Authors:  Megan E Bosch; Amy Aldrich; Rachel Fallet; Jessica Odvody; Maria Burkovetskaya; Kaitlyn Schuberth; Julie A Fitzgerald; Kevin D Foust; Tammy Kielian
Journal:  J Neurosci       Date:  2016-09-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.